Key result
Conservative management of adrenal myelolipomas is viable for most patients, as 13 of 15 patients followed without surgery remained asymptomatic over an average of 3.2 years.
Why the study?
Is conservative management safe and appropriate for patients with adrenal myelolipoma?
Observational (n=20)
Is conservative management safe and appropriate for patients with adrenal myelolipoma?
The majority of adrenal myelolipomas can be safely managed conservatively, as tumor growth is variable and does not necessarily correlate with symptoms.
No takes yet. Share an insight, caveat, or question.
May support conservative management in selected patients; leaves open need for larger prospective validation.
Han et al. (1997) conducted an observational in Adrenal myelolipoma (n=20). Conservative management vs. Surgical intervention was evaluated on Symptom progression and tumor growth. Conservative management of adrenal myelolipomas is viable for most patients, as 13 of 15 patients followed without surgery remained asymptomatic over an average of 3.2 years.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: